Medivir AB (publ) (STO:MVIR)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.604
-0.106 (-6.20%)
At close: Feb 27, 2026

Medivir AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
864184319159552624
Market Cap Growth
227.79%-42.39%100.21%-71.16%-11.61%209.74%
Enterprise Value
753167236110424411
Last Close Price
1.600.412.842.858.119.18
PS Ratio
101.6521.5991.4320.85125.1519.27
PB Ratio
3.270.692.760.732.862.22
P/TBV Ratio
3.270.692.760.732.862.22
EV/Sales Ratio
88.5919.6167.6114.4096.2712.69
Debt / Equity Ratio
0.030.030.100.060.080.05
Net Debt / Equity Ratio
-0.42-0.42-0.44-0.72-0.53-0.74
Net Debt / EBITDA Ratio
1.841.840.401.681.153.23
Net Debt / FCF Ratio
1.511.510.412.611.004.25
Asset Turnover
0.040.040.020.030.020.12
Quick Ratio
3.663.661.363.034.375.40
Current Ratio
3.663.661.383.054.395.42
Return on Equity (ROE)
-49.68%-49.68%-73.97%-43.50%-37.46%-29.84%
Return on Assets (ROA)
-24.27%-24.27%-34.76%-22.21%-19.43%-15.27%
Return on Invested Capital (ROIC)
-92.03%-85.50%-203.28%-121.40%-107.49%-79.32%
Return on Capital Employed (ROCE)
-34.10%-34.10%-103.20%-40.50%-43.00%-21.90%
Earnings Yield
-10.93%-51.44%-38.71%-56.14%-16.09%-10.11%
FCF Yield
--39.94%-38.99%-37.50%-18.53%-7.81%
Buyback Yield / Dilution
-25.08%-25.08%-88.71%-8.44%-5.53%-117.45%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.